Evaluating the effects of Crocus sativus L. (Saffron) on weight and depressio

Not Applicable

• Conditions: Condition 1: Mild Depression. Condition 2: Moderate depression. Condition 3: Obseity.; Mild depressive episode Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities.; Moderate depressive episode Four or more of the above symptoms are usually present and the patient is likely to have great difficulty in continuing with ordinary activities.; Obesity due to excess calories

• Registration Number: IRCT2014041916465N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Age 18 to 50 years; females; Body Mass Index above 25; patients with mild (minor) depression based on semi- structured diagnostic interview by a psychiatrist; to sign a consent form

Exclusion Criteria

Those who are taking antidepressants; severe (major) depression; psychotic depression or have suicidal thoughts; use of anti-inflammatory glucocorticoids, and steroids; those who take medicines to reduce appetite or weight; those with diabetes who are taking medications or insulin; those with heart disease or hypercholesterolemia who are taking medication (statins, fibrates, diuretics); those how are taking oral anti-inflammatory drugs corticosteroids or any drug that causes weight loss or gain; taking hormonal contraceptives; pregnancy and lactation; menopause; severe mental disorder; schizophrenia and bipolar; hypothyroidism; exercise professionals; those with special diets such as the diets for kidney disorders.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight. Timepoint: At baseline and at weeks 2, 4, 8 and 12 after the bigining of the study. Method of measurement: Standard scales Seca.;Body Mass Index. Timepoint: At baseline and at weeks 2, 4, 8 and 12 after the bigining of the study. Method of measurement: kg/(m)2.;Depression. Timepoint: At baseline and at weeks 2, 4, 8 and 12 after the bigining of the study. Method of measurement: Hamilton rating scale for depression.